Product Information
BROMSITE 0.075% EYE DROPS is a brand product labeled by Sun Pharmaceutical Industries Inc., priced at $49.5534 per ML under NDC 49708075441. Its NADAC has been published 498 times since Feb 22, 2017.
FDA first approved this application on Apr 8, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.76 mg/mL
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
49708075441
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
BROMFENAC SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA206911FDA Approved
4/8/2016
TE Code
AB
On Market Since
5/1/2016
Pharmacological Classes
Price Statistics
The NADAC for BROMSITE 0.075% EYE DROPS has been published 498 times since Feb 22, 2017, and over the history we have for it it has risen 9.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $49.5534 per ML |
|---|---|
| All-time high | $49.8920 (Nov 13, 2019) |
| All-time low | $45.1387 (Feb 22, 2017) |
| 52-week high | $49.7699 |
| 52-week low | $49.5434 |
| Median price | $49.6749 |
| Average price | $49.3557 |
| Largest weekly change | +8.0% (Feb 7, 2018) |
| Weeks tracked | 498 |
| Tracking since | Feb 22, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 51% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
bromfenac market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BROMSITE 0.075% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for BROMSITE 0.075% EYE DROPS, manufactured by Sun Pharmaceutical Industries Inc., is $49.5534 per ML (NDC 49708075441), effective Sep 30, 2026.
How has the price of BROMSITE 0.075% EYE DROPS changed over time?
Over the history we have for it, the NADAC for BROMSITE 0.075% EYE DROPS has risen 9.8%. It has been tracked across 498 weekly CMS publications since Feb 22, 2017.
What are the highest and lowest recorded NADAC prices for BROMSITE 0.075% EYE DROPS?
Since Feb 22, 2017, the NADAC for BROMSITE 0.075% EYE DROPS has ranged from a low of $45.1387 (Feb 22, 2017) to a high of $49.8920 (Nov 13, 2019), with a median of $49.6749 per ML.
Are there cheaper alternatives to BROMSITE 0.075% EYE DROPS?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BROMFENAC SOD 0.075% EYE DROP, is $24.3848 per ML — about 51% below BROMSITE 0.075% EYE DROPS.
Who manufactures BROMSITE 0.075% EYE DROPS?
BROMSITE 0.075% EYE DROPS (NDC 49708075441) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a brand product.